Parabilis sets a record with a $670M biotech IPO

AI Summary

Parabilis achieved a record $670 million IPO, marking the largest new stock sale for a venture-backed biotech company and contributing to over $4.1 billion raised by drug startups in 2026.

The largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now resulted in 12 drug startups securing more than $4.1 billion combined.